Sionna Therapeutics SION
NASDAQ SION
$3.78 +0.08 (+2.16%)
As of: Nov 11, 2026 · 12:49 PM EST

Sionna Therapeutics (SION) Return on Assets [ROA] (2025 - 2026)

Updated

Sionna Therapeutics' Return on Assets [ROA] was -33.13% in Q2 2026, down 11.92 percentage points from -21.21% a year earlier and down 5.93 percentage points from the prior quarter.

Analysis

Sionna Therapeutics (SION) Return on Assets [ROA] (2025 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Sionna Therapeutics came in at -29.58%.

  • Per Business Quant data, SION's Return on Assets [ROA] in the three quarters before Q2 2026 was -27.20% (Q1 2026), -22.76% (Q4 2025) and -20.62% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Sionna Therapeutics 167.27 Mn -720.38 Mn - -40.50%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -40.50%
Jun 30, 2026 -33.32%
Mar 31, 2026 -27.24%
Dec 31, 2025 -22.58%
Sep 30, 2025 -20.55%
Jun 30, 2025 -20.92%
Mar 31, 2025 -23.77%
API Access

Sionna Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SION&period=max&api_key=YOUR_API_KEY